Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe Added to Statin vs Doubling Statin Dose in Hypercholesterolemia
NCT00652327Phase 4Completed
- Sponsor
- Organon & Co.
- Start
- Dec 2005
- Primary completion
- Jul 2007
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of ezetimibe in hypercholesterolemia (2 arms), sponsored by Organon & Co. Primary endpoint: Percentage Change in Low Density Lipoprotein-Cholesterol From Baseline at 8 weeks. Started Dec 2005; status: completed.
02
Drugs
ezetimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00652327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00652327.